ZNF546
gene geneOn this page
Also known as MGC43537
Summary
ZNF546 (zinc finger protein 546, HGNC:28671) is a protein-coding gene on chromosome 19q13.2, encoding Zinc finger protein 546 (Q86UE3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in membrane. Predicted to be active in nucleus.
Source: NCBI Gene 339327 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 66 total
- MANE Select transcript:
NM_178544
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28671 |
| Approved symbol | ZNF546 |
| Name | zinc finger protein 546 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC43537 |
| Ensembl gene | ENSG00000187187 |
| Ensembl biotype | protein_coding |
| Entrez | 339327 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 7 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000347077, ENST00000593687, ENST00000595225, ENST00000596894, ENST00000597363, ENST00000599504, ENST00000600094, ENST00000601138, ENST00000602253, ENST00000651981, ENST00000951738
RefSeq mRNA: 2 — MANE Select: NM_178544
NM_001297763, NM_178544
CCDS: CCDS12548, CCDS77297
Canonical transcript exons
ENST00000347077 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001338702 | 39998248 | 39998410 |
| ENSE00001414802 | 39997861 | 39997915 |
| ENSE00001432294 | 40013665 | 40021038 |
| ENSE00002506963 | 40007274 | 40007400 |
| ENSE00002522561 | 40008470 | 40008565 |
| ENSE00003036812 | 39997060 | 39997157 |
| ENSE00003563175 | 40006096 | 40006182 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 87.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.4641 / max 39.6955, expressed in 1053 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175811 | 2.0975 | 916 |
| 175812 | 0.3666 | 150 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 87.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.04 | gold quality |
| right testis | UBERON:0004534 | 83.23 | gold quality |
| left testis | UBERON:0004533 | 82.58 | gold quality |
| calcaneal tendon | UBERON:0003701 | 82.31 | gold quality |
| testis | UBERON:0000473 | 82.18 | gold quality |
| adrenal tissue | UBERON:0018303 | 79.26 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.10 | gold quality |
| endometrium | UBERON:0001295 | 76.89 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.70 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.64 | gold quality |
| cerebellum | UBERON:0002037 | 75.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 75.42 | gold quality |
| apex of heart | UBERON:0002098 | 75.26 | gold quality |
| muscle tissue | UBERON:0002385 | 75.21 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 74.89 | gold quality |
| ovary | UBERON:0000992 | 74.88 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.74 | gold quality |
| left ovary | UBERON:0002119 | 74.68 | gold quality |
| muscle of leg | UBERON:0001383 | 74.46 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 74.37 | gold quality |
| right adrenal gland | UBERON:0001233 | 74.32 | gold quality |
| right ovary | UBERON:0002118 | 74.23 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.21 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.87 | gold quality |
| adrenal gland | UBERON:0002369 | 73.86 | gold quality |
| right uterine tube | UBERON:0001302 | 73.71 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.42 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 73.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 73.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.78 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
160 targeting ZNF546, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 546 — Q86UE3 (reviewed: Q86UE3)
Alternative names: Zinc finger protein 49
All UniProt accessions (7): A0A494C1I4, Q86UE3, M0QXH5, M0QXR6, M0QY24, M0QZB2, M0R292
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001284692, NP_848639* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (33 total): zinc finger region 22, sequence variant 8, chain 1, domain 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86UE3-F1 | 73.95 | 0.04 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 179
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 79 (showing top):
GGAMTNNNNNTCCY_UNKNOWN, KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION, STAT1_02, YKACATTT_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STAT1_03, SNACANNNYSYAGA_UNKNOWN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, DIDO1_TARGET_GENES, FEV_TARGET_GENES, NFE2L1_TARGET_GENES, NKX2_3_TARGET_GENES, TEAD2_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF223_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
374 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF546 | ZNF438 | Q7Z4V0 | 552 |
| ZNF546 | OR8D2 | Q9GZM6 | 488 |
| ZNF546 | KRT83 | P78385 | 450 |
| ZNF546 | OR2M7 | Q8NG81 | 438 |
| ZNF546 | TRAT1 | Q6PIZ9 | 429 |
| ZNF546 | C19orf47 | Q8N9M1 | 419 |
| ZNF546 | SULT1C3 | Q6IMI6 | 413 |
| ZNF546 | MTA1 | Q13330 | 401 |
| ZNF546 | ACTMAP | Q5BKX5 | 400 |
| ZNF546 | NKAPL | Q5M9Q1 | 399 |
| ZNF546 | OR10C1 | Q96KK4 | 396 |
| ZNF546 | ADD1 | P35611 | 390 |
| ZNF546 | KRT3 | P12035 | 375 |
| ZNF546 | LRRC66 | Q68CR7 | 375 |
| ZNF546 | MAP4 | P27816 | 363 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CBX4 | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF546 | CALU | psi-mi:“MI:0914”(association) | 0.350 |
| EPHA1 | ZNF546 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): ZNF546 (Affinity Capture-MS), ZNF546 (Proximity Label-MS), ZNF546 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1101 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:40006094:A:AG | acceptor_gain | 1.0000 |
| 19:40006095:G:GG | acceptor_gain | 1.0000 |
| 19:40006095:GCCCC:G | acceptor_gain | 1.0000 |
| 19:40007399:GG:G | donor_gain | 1.0000 |
| 19:40007400:GG:G | donor_gain | 1.0000 |
| 19:40007401:G:GC | donor_loss | 1.0000 |
| 19:40007401:G:GG | donor_gain | 1.0000 |
| 19:40008463:T:G | acceptor_gain | 1.0000 |
| 19:39997843:T:TA | acceptor_gain | 0.9900 |
| 19:40006094:AGC:A | acceptor_loss | 0.9900 |
| 19:40006095:GC:G | acceptor_gain | 0.9900 |
| 19:40006181:AT:A | donor_gain | 0.9900 |
| 19:40006183:G:GG | donor_gain | 0.9900 |
| 19:40008468:AG:A | acceptor_gain | 0.9900 |
| 19:40008469:GG:G | acceptor_gain | 0.9900 |
| 19:40008469:GGAT:G | acceptor_gain | 0.9900 |
| 19:39997839:ATTCT:A | acceptor_gain | 0.9800 |
| 19:40006095:GCC:G | acceptor_gain | 0.9800 |
| 19:40008462:A:AG | acceptor_gain | 0.9800 |
| 19:40008462:AT:A | acceptor_gain | 0.9800 |
| 19:40008463:T:TA | acceptor_gain | 0.9800 |
| 19:40008464:GAGCA:G | acceptor_loss | 0.9800 |
| 19:40008467:CAGGA:C | acceptor_loss | 0.9800 |
| 19:40008468:AGG:A | acceptor_loss | 0.9800 |
| 19:40008469:G:T | acceptor_loss | 0.9800 |
| 19:40008561:CACAG:C | donor_loss | 0.9800 |
| 19:40008562:ACAG:A | donor_loss | 0.9800 |
| 19:40008563:CAGGT:C | donor_loss | 0.9800 |
| 19:40008564:AG:A | donor_loss | 0.9800 |
| 19:40008565:GG:G | donor_loss | 0.9800 |
AlphaMissense
5599 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:40014450:T:C | F394L | 0.997 |
| 19:40014452:T:A | F394L | 0.997 |
| 19:40014452:T:G | F394L | 0.997 |
| 19:40014702:T:C | F478L | 0.997 |
| 19:40014704:T:A | F478L | 0.997 |
| 19:40014704:T:G | F478L | 0.997 |
| 19:40014198:T:C | F310L | 0.996 |
| 19:40014200:T:A | F310L | 0.996 |
| 19:40014200:T:G | F310L | 0.996 |
| 19:40014618:T:C | F450L | 0.996 |
| 19:40014620:T:A | F450L | 0.996 |
| 19:40014620:T:G | F450L | 0.996 |
| 19:40015122:T:C | F618L | 0.996 |
| 19:40015124:T:A | F618L | 0.996 |
| 19:40015124:T:G | F618L | 0.996 |
| 19:40015206:T:C | F646L | 0.996 |
| 19:40015208:T:A | F646L | 0.996 |
| 19:40015208:T:G | F646L | 0.996 |
| 19:40014282:T:C | F338L | 0.995 |
| 19:40014284:T:A | F338L | 0.995 |
| 19:40014284:T:G | F338L | 0.995 |
| 19:40014870:T:C | F534L | 0.995 |
| 19:40014872:T:A | F534L | 0.995 |
| 19:40014872:T:G | F534L | 0.995 |
| 19:40014030:T:C | F254L | 0.994 |
| 19:40014032:T:A | F254L | 0.994 |
| 19:40014032:T:G | F254L | 0.994 |
| 19:40014114:T:C | F282L | 0.994 |
| 19:40014116:T:A | F282L | 0.994 |
| 19:40014116:T:G | F282L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000019536 (19:40005974 T>C,G), RS1000025413 (19:40001688 T>G), RS1000056404 (19:40000416 A>G), RS1000125072 (19:40000804 C>G,T), RS1000308853 (19:40007543 T>G), RS1000346726 (19:40008267 G>A), RS1000641283 (19:39995690 G>A,C,T), RS1000649454 (19:39996361 G>C), RS1000914246 (19:40009252 G>A), RS1000918694 (19:40016348 C>T), RS1000972580 (19:39995441 G>A), RS1001052638 (19:40015407 A>C,G), RS1001261469 (19:40009574 T>C), RS1001390695 (19:40016708 C>T), RS1001441617 (19:40016389 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Rifampin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.